Adverse effects of fructose on cardiometabolic risk factors and hepatic lipid metabolism in subjects with abdominal obesity

Obesity and Bariatric Surgery

Does Cardiorespiratory Fitness Attenuate the Adverse Effects of Severe/Morbid Obesity on Cardiometabolic Risk and Insulin Resistance in Children? A Pooled Analysis

Diabetes Care.

Nyström CD, Henriksson P, Martínez-Vizcaíno V, Medrano M, Cadenas-Sanchez C, Arias-Palencia NM, Löf M, Ruiz JR, Labayen I, Sánchez-López M, Ortega FB

doi: 10.2337/dc17-1334.

RECOMMENDED

Obesity and Bariatric Surgery

The Effect of Liquid Meal Replacements on Cardiometabolic Risk Factors in Overweight/Obese Individuals With Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials

Diabetes Care.

Noronha JC, Nishi SK, Braunstein CR, Khan TA, Blanco Mejia S, Kendall CWC, Kahleová H, Rahelić D, Salas-Salvadó J, Leiter LA, Sievenpiper JL

doi: 10.2337/dc18-2270.

COMMENTED

Type 2 DiabetesObesity and Bariatric Surgery

Association of Metabolic Surgery With Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity

JAMA.

Aminian A, Zajichek A, Arterburn DE, Wolski KE, Brethauer SA, Schauer PR, Kattan MW, Nissen SE

doi: 10.1001/jama.2019.14231.

Obesity and Bariatric Surgery

Metabolically Healthy Obesity, Transition to Metabolic Syndrome, and Cardiovascular Risk

J Am Coll Cardiol.

Mongraw-Chaffin M, Foster MC, Anderson CAM, Burke GL, Haq N, Kalyani RR, Ouyang P, Sibley CT, Tracy R, Woodward M, Vaidya D

doi: 10.1016/j.jacc.2018.02.055.

Diabetes - GeneralType 2 DiabetesLipids

Elevations of metabolic risk factors 20 years or more before diagnosis of type 2 diabetes - experience from the AMORIS study

Diabetes Obes Metab.

Malmström H, Walldius G, Carlsson S, Grill V, Jungner I, Gudbjörnsdottir S, Kosiborod M, Hammar N

doi: 10.1111/dom.13241.

Glycemic ControlObesity and Bariatric Surgery

Effects of Diazoxide-mediated Insulin Suppression on Glucose and Lipid metabolism in Non-Diabetic Obese Men

J Clin Endocrinol Metab.

Loves S, van Groningen L, Filius M, Mekking M, Brandon T, Tack CJ, Hermus A, de Boer H

doi: 10.1210/jc.2018-00161.

COMMENTED

Diabetes - GeneralType 2 DiabetesGlycemic Control

Short-term progression of cardiometabolic risk factors in relation to age at type 2 diabetes diagnosis: a longitudinal observational study of 100,606 individuals from the Swedish National Diabetes Register

Diabetologia.

Steinarsson AO, Rawshani A, Gudbjörnsdottir S, Franzén S, Svensson AM, Sattar N

doi: 10.1007/

Obesity and Bariatric Surgery

Lorcaserin treatment decreases body weight and improves cardiometabolic risk factors of obese adults: A 6-month-long, randomized, placebo-controlled, double-blind clinical trial

Diabetes Obes Metab.

Tuccinardi D, Farr OM, Upadhyay J, Oussaada SM, Mathew H, Paschou SA, Perakakis N, Koniaris A, Kelesidis T, Mantzoros CS

doi: 10.1111/dom.

Obesity and Bariatric Surgery

Effect of one-anastomosis gastric bypass on cardiovascular risk factors in patients with vitamin D deficiency and morbid obesity: A secondary analysis

Nutr Metab Cardiovasc Dis.

Kruschitz R, Wakolbinger M, Schindler K, Prager G, Hoppichler F, Marculescu R, Ludvik B

doi: 10.1016/j.numecd.

Related content

Does Cardiorespiratory Fitness Attenuate the Adverse Effects of Severe/Morbid Obesity on Cardiometabolic Risk and Insulin Resistance in Children? A Pooled Analysis

The Effect of Liquid Meal Replacements on Cardiometabolic Risk Factors in Overweight/Obese Individuals With Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials

Association of Metabolic Surgery With Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity

Metabolically Healthy Obesity, Transition to Metabolic Syndrome, and Cardiovascular Risk

Elevations of metabolic risk factors 20 years or more before diagnosis of type 2 diabetes - experience from the AMORIS study

Effects of Diazoxide-mediated Insulin Suppression on Glucose and Lipid metabolism in Non-Diabetic Obese Men

Short-term progression of cardiometabolic risk factors in relation to age at type 2 diabetes diagnosis: a longitudinal observational study of 100,606 individuals from the Swedish National Diabetes Register

Lorcaserin treatment decreases body weight and improves cardiometabolic risk factors of obese adults: A 6-month-long, randomized, placebo-controlled, double-blind clinical trial

Effect of one-anastomosis gastric bypass on cardiovascular risk factors in patients with vitamin D deficiency and morbid obesity: A secondary analysis